Building better strategies to develop new medications in Alcohol Use Disorder: Learning from past success and failure to shape a brighter future

[1]  G. Koob,et al.  Inactivation of a CRF-dependent amygdalofugal pathway reverses addiction-like behaviors in alcohol-dependent rats , 2019, Nature Communications.

[2]  G. Gessa,et al.  Anti-addictive properties of COR659 - Additional pharmacological evidence and comparison with a series of novel analogues. , 2019, Alcohol.

[3]  F. Weiss,et al.  phMRI, neurochemical and behavioral responses to psychostimulants distinguishing genetically selected alcohol‐preferring from genetically heterogenous rats , 2018, Addiction biology.

[4]  R. Spanagel,et al.  Efficacy and side effects of baclofen and the novel GABAB receptor positive allosteric modulator CMPPE in animal models for alcohol and cocaine addiction , 2018, Psychopharmacology.

[5]  J. Csernansky,et al.  Corticotrophin releasing factor receptor 1 antagonists prevent chronic stress-induced behavioral changes and synapse loss in aged rats , 2018, Psychoneuroendocrinology.

[6]  David M. Shackleford,et al.  Muscarinic M5 receptors modulate ethanol seeking in rats , 2018, Neuropsychopharmacology.

[7]  B. Rothbaum,et al.  Corticotropin-Releasing Factor Receptor 1 Antagonism Is Ineffective for Women With Posttraumatic Stress Disorder , 2017, Biological Psychiatry.

[8]  Joseph P. Schacht,et al.  Dopaminergic Genetic Variation Influences Aripiprazole Effects on Alcohol Self-Administration and the Neural Response to Alcohol Cues in a Randomized Trial , 2017, Neuropsychopharmacology.

[9]  M. Pirmohamed,et al.  Systematic review: Baclofen dosing protocols for alcohol use disorders used in observational studies , 2017, European Neuropsychopharmacology.

[10]  L. Parsons,et al.  Constitutive Increases in Amygdalar Corticotropin-Releasing Factor and Fatty Acid Amide Hydrolase Drive an Anxious Phenotype , 2017, Biological Psychiatry.

[11]  David Moratal,et al.  Multi‐modal MRI classifiers identify excessive alcohol consumption and treatment effects in the brain , 2017, Addiction biology.

[12]  M. Soyka,et al.  Pharmacotherapy of alcoholism – an update on approved and off-label medications , 2017, Expert opinion on pharmacotherapy.

[13]  J. P. Hamilton,et al.  The GABAB Positive Allosteric Modulator ADX71441 Attenuates Alcohol Self-Administration and Relapse to Alcohol Seeking in Rats , 2017, Neuropsychopharmacology.

[14]  T. E. Thiele,et al.  The Role of Orexin Signaling in the Ventral Tegmental Area and Central Amygdala in Modulating Binge‐Like Ethanol Drinking Behavior , 2017, Alcoholism, clinical and experimental research.

[15]  F. Weiss,et al.  Genetic Deletion of the Nociceptin/Orphanin FQ Receptor in the Rat Confers Resilience to the Development of Drug Addiction , 2017, Neuropsychopharmacology.

[16]  Reza Momenan,et al.  Model‐free functional connectivity and impulsivity correlates of alcohol dependence: a resting‐state study , 2017, Addiction biology.

[17]  David E. Moorman,et al.  Orexin/hypocretin-1 receptor antagonism reduces ethanol self-administration and reinstatement selectively in highly-motivated rats , 2017, Brain Research.

[18]  Dustin Scheinost,et al.  Cingulate cortex functional connectivity predicts future relapse in alcohol dependent individuals , 2016, NeuroImage: Clinical.

[19]  R. Mohs,et al.  Proof-of-Concept Study to Assess the Nociceptin Receptor Antagonist LY2940094 as a New Treatment for Alcohol Dependence. , 2016, Alcoholism, clinical and experimental research.

[20]  Bing Hu,et al.  Nucleus Accumbens Shell and mPFC but Not Insula Orexin-1 Receptors Promote Excessive Alcohol Drinking , 2016, Front. Neurosci..

[21]  F. Cadaveira,et al.  Functional and structural brain connectivity of young binge drinkers: a follow-up study , 2016, Scientific Reports.

[22]  J. Budzyński,et al.  Orexin in Patients with Alcohol Dependence Treated for Relapse Prevention: A Pilot Study. , 2016, Alcohol and alcoholism.

[23]  C. Cifani,et al.  Neuropeptide S differently modulates alcohol-related behaviors in alcohol-preferring and non-preferring rats , 2016, Psychopharmacology.

[24]  F. Weiss,et al.  A Novel, Orally Bioavailable Nociceptin Receptor Antagonist, LY2940094, Reduces Ethanol Self-Administration and Ethanol Seeking in Animal Models. , 2016, Alcoholism, clinical and experimental research.

[25]  M. Schwandt,et al.  The CRF1 Antagonist Verucerfont in Anxious Alcohol-Dependent Women: Translation of Neuroendocrine, But not of Anti-Craving Effects , 2016, Neuropsychopharmacology.

[26]  Sam R. Miller,et al.  Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype , 2016, Neuropsychopharmacology.

[27]  R. Ciccocioppo,et al.  Activation of Hypocretin-1/Orexin-A Neurons Projecting to the Bed Nucleus of the Stria Terminalis and Paraventricular Nucleus Is Critical for Reinstatement of Alcohol Seeking by Neuropeptide S , 2016, Biological Psychiatry.

[28]  R. Spanagel,et al.  Convergent evidence from alcohol-dependent humans and rats for a hyperdopaminergic state in protracted abstinence , 2016, Proceedings of the National Academy of Sciences.

[29]  M. Schwandt,et al.  Resting‐state functional connectivity and presynaptic monoamine signaling in Alcohol Dependence , 2015, Human brain mapping.

[30]  A. Goudriaan,et al.  Resting state connectivity in alcohol dependent patients and the effect of repetitive transcranial magnetic stimulation , 2015, European Neuropsychopharmacology.

[31]  Robert D Brewer,et al.  2010 National and State Costs of Excessive Alcohol Consumption. , 2015, American journal of preventive medicine.

[32]  M. Heilig,et al.  Neurokinin 1 receptor blockade in the medial amygdala attenuates alcohol drinking in rats with innate anxiety but not in Wistar rats , 2015, British journal of pharmacology.

[33]  A. Pfefferbaum,et al.  The Resting Brain of Alcoholics. , 2015, Cerebral cortex.

[34]  J. Franck,et al.  Varenicline for treatment of alcohol dependence: a randomized, placebo-controlled trial. , 2015, Alcoholism, clinical and experimental research.

[35]  T. Kosten,et al.  Differential effects of ghrelin antagonists on alcohol drinking and reinforcement in mouse and rat models of alcohol dependence , 2015, Neuropharmacology.

[36]  A. Heinz,et al.  High-dose baclofen for the treatment of alcohol dependence (BACLAD study): A randomized, placebo-controlled trial , 2015, European Neuropsychopharmacology.

[37]  R. Litten,et al.  Moderators of Varenicline Treatment Effects in a Double-Blind, Placebo-Controlled Trial for Alcohol Dependence: An Exploratory Analysis , 2015, Journal of addiction medicine.

[38]  S. Leibowitz,et al.  Anterior thalamic paraventricular nucleus is involved in intermittent access ethanol drinking: role of orexin receptor 2 , 2015, Addiction biology.

[39]  D. Oslin,et al.  Naltrexone vs Placebo for the Treatment of Alcohol Dependence: A Randomized Clinical Trial. , 2015, JAMA psychiatry.

[40]  Elizabeth A. Hale,et al.  The CRH1 Antagonist GSK561679 Increases Human Fear But Not Anxiety as Assessed by Startle , 2015, Neuropsychopharmacology.

[41]  M. Schwandt,et al.  The Corticotropin Releasing Hormone-1 (CRH1) Receptor Antagonist Pexacerfont in Alcohol Dependence: A Randomized Controlled Experimental Medicine Study , 2015, Neuropsychopharmacology.

[42]  G. Koob,et al.  Chronic CRF1 receptor blockade reduces heroin intake escalation and dependence‐induced hyperalgesia , 2015, Addiction biology.

[43]  M. Heilig,et al.  Polymorphism in the corticotropin-releasing factor receptor 1 (CRF1-R) gene plays a role in shaping the high anxious phenotype of Marchigian Sardinian alcohol-preferring (msP) rats , 2015, Psychopharmacology.

[44]  D. Ciraulo,et al.  Zonisamide, Topiramate, and Levetiracetam , 2014, Journal of clinical psychopharmacology.

[45]  L. Leggio,et al.  Intravenous Ghrelin Administration Increases Alcohol Craving in Alcohol-Dependent Heavy Drinkers: A Preliminary Investigation , 2014, Biological Psychiatry.

[46]  K. Jardemark,et al.  Evaluation of Guanfacine as a Potential Medication for Alcohol Use Disorder in Long-Term Drinking Rats: Behavioral and Electrophysiological Findings , 2014, Neuropsychopharmacology.

[47]  L. M. Valor,et al.  Binge-like consumption of caloric and non-caloric palatable substances in ad libitum-fed C57BL/6J mice: Pharmacological and molecular evidence of orexin involvement , 2014, Behavioural Brain Research.

[48]  D. Economidou,et al.  Chronic Treatment with Novel Brain-Penetrating Selective NOP Receptor Agonist MT-7716 Reduces Alcohol Drinking and Seeking in the Rat , 2014, Neuropsychopharmacology.

[49]  Leah C. S. Cepko,et al.  Ghrelin alters the stimulatory effect of cocaine on ethanol intake following mesolimbic or systemic administration , 2014, Neuropharmacology.

[50]  M. Heilig,et al.  Polymorphism in the corticotropin-releasing factor receptor 1 (CRF1-R) gene plays a role in shaping the high anxious phenotype of Marchigian Sardinian alcohol-preferring (msP) rats , 2014, Psychopharmacology.

[51]  J. Gómez,et al.  The effects of ghrelin antagonists [D-Lys(3) ]-GHRP-6 or JMV2959 on ethanol, water, and food intake in C57BL/6J mice. , 2014, Alcoholism, clinical and experimental research.

[52]  Cassandra J Rowe,et al.  Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis. , 2014, JAMA.

[53]  R. Spanagel,et al.  The alcohol deprivation effect model for studying relapse behavior: a comparison between rats and mice. , 2014, Alcohol.

[54]  D. Ghahremani,et al.  Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findings , 2014, Psychopharmacology.

[55]  G. Koob,et al.  Corticotropin releasing factor: A key role in the neurobiology of addiction , 2014, Frontiers in Neuroendocrinology.

[56]  Joseph P. Schacht,et al.  Varenicline effects on drinking, craving and neural reward processing among non-treatment-seeking alcohol-dependent individuals , 2014, Psychopharmacology.

[57]  D. Kanny,et al.  Alcohol-Attributable Deaths and Years of Potential Life Lost — 11 States, 2006–2010 , 2014, MMWR. Morbidity and mortality weekly report.

[58]  J. Pintar,et al.  The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence. , 2014, Pharmacology & therapeutics.

[59]  R. Spanagel,et al.  Acamprosate Produces Its Anti-Relapse Effects Via Calcium , 2014, Neuropsychopharmacology.

[60]  F. Weiss,et al.  N‐(2‐methyl‐6‐benzoxazolyl)‐N′‐1,5‐naphthyridin‐4‐yl urea (SB334867), a hypocretin receptor‐1 antagonist, preferentially prevents ethanol seeking: comparison with natural reward seeking , 2014, Addiction biology.

[61]  H. Becker,et al.  Orexin-1 and orexin-2 receptor antagonists reduce ethanol self-administration in high-drinking rodent models , 2014, Front. Neurosci..

[62]  T. Vos,et al.  Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010 , 2013, The Lancet.

[63]  K. Mann,et al.  A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence , 2013, European Neuropsychopharmacology.

[64]  A. Lawrence,et al.  Central orexin (hypocretin) 2 receptor antagonism reduces ethanol self-administration, but not cue-conditioned ethanol-seeking, in ethanol-preferring rats. , 2013, The international journal of neuropsychopharmacology.

[65]  K. Miczek,et al.  Reduction of excessive alcohol drinking by a novel GABAB receptor positive allosteric modulator ADX71441 in mice , 2013, Psychopharmacology.

[66]  E. Jerlhag,et al.  Ghrelin Receptor (GHS-R1A) Antagonism Suppresses Both Alcohol Consumption and the Alcohol Deprivation Effect in Rats following Long-Term Voluntary Alcohol Consumption , 2013, PloS one.

[67]  J. Franck,et al.  Pharmacotherapy for alcohol dependence: status of current treatments , 2013, Current Opinion in Neurobiology.

[68]  D. Ciraulo,et al.  A Double-Blind, Placebo-Controlled Trial Assessing the Efficacy of Varenicline Tartrate for Alcohol Dependence , 2013, Journal of addiction medicine.

[69]  Jean Martinez,et al.  Ghrelin knockout mice show decreased voluntary alcohol consumption and reduced ethanol-induced conditioned place preference , 2013, Peptides.

[70]  A. Ryabinin,et al.  The CRF system and social behavior: a review , 2013, Front. Neurosci..

[71]  K. Mann,et al.  Extending the Treatment Options in Alcohol Dependence: A Randomized Controlled Study of As-Needed Nalmefene , 2013, Biological Psychiatry.

[72]  K. Björk,et al.  Role of a Genetic Polymorphism in the Corticotropin-Releasing Factor Receptor 1 Gene in Alcohol Drinking and Seeking Behaviors of Marchigian Sardinian Alcohol-Preferring Rats , 2013, Front. Psychiatry.

[73]  Angelo Bifone,et al.  Reduced limbic metabolism and fronto-cortical volume in rats vulnerable to alcohol addiction , 2013, NeuroImage.

[74]  D. Wong,et al.  Influence of OPRM1 Asn40Asp variant (A118G) on [11C]carfentanil binding potential: preliminary findings in human subjects. , 2013, The international journal of neuropsychopharmacology.

[75]  Scott Henderson,et al.  Interacting Effects of Naltrexone and OPRM1 and DAT1 Variation on the Neural Response to Alcohol Cues , 2013, Neuropsychopharmacology.

[76]  G. Gessa,et al.  Reduction of alcohol intake by the positive allosteric modulator of the GABA(B) receptor, rac-BHFF, in alcohol-preferring rats. , 2013, Alcohol.

[77]  R. Sinha,et al.  Stress system changes associated with marijuana dependence may increase craving for alcohol and cocaine , 2013, Human psychopharmacology.

[78]  A. Lawrence,et al.  The phosphodiesterase-4 (PDE4) inhibitor rolipram decreases ethanol seeking and consumption in alcohol-preferring Fawn-Hooded rats. , 2012, Alcoholism, clinical and experimental research.

[79]  G. Gessa,et al.  Comparison of the effect of the GABAΒ receptor agonist, baclofen, and the positive allosteric modulator of the GABAB receptor, GS39783, on alcohol self-administration in 3 different lines of alcohol-preferring rats. , 2012, Alcoholism, clinical and experimental research.

[80]  H. Marston,et al.  The glycine reuptake inhibitor Org24598 and acamprosate reduce ethanol intake in the rat; tolerance development to acamprosate but not to Org24598 , 2012, Addiction biology.

[81]  A. Sartorius,et al.  Translational Magnetic Resonance Spectroscopy Reveals Excessive Central Glutamate Levels During Alcohol Withdrawal in Humans and Rats , 2012, Biological Psychiatry.

[82]  D. Grigoriadis,et al.  Binding Kinetics Redefine the Antagonist Pharmacology of the Corticotropin-Releasing Factor Type 1 Receptor , 2012, Journal of Pharmacology and Experimental Therapeutics.

[83]  Cari A. Lehigh,et al.  fMRI of the brain’s response to stimuli experimentally paired with alcohol intoxication , 2012, Psychopharmacology.

[84]  Ashley R. Smith,et al.  The effect of intravenous alcohol on the neural correlates of risky decision making in healthy social drinkers , 2012, Addiction biology.

[85]  W. Mcbride,et al.  Effects of naltrexone and LY255582 on ethanol maintenance, seeking, and relapse responding by alcohol-preferring (P) rats. , 2012, Alcohol.

[86]  R. Sinha,et al.  Prazosin effects on stress- and cue-induced craving and stress response in alcohol-dependent individuals: preliminary findings. , 2012, Alcoholism, clinical and experimental research.

[87]  P. Hyytiä,et al.  Ghrelin receptor (GHS‐R1A) antagonism suppresses both operant alcohol self‐administration and high alcohol consumption in rats , 2012, Addiction biology.

[88]  D. Goldman,et al.  Pharmacogenetic approaches to the treatment of alcohol addiction , 2011, Nature Reviews Neuroscience.

[89]  K. Mann,et al.  Alcohol and the human brain: a systematic review of different neuroimaging methods. , 2011, Alcoholism, clinical and experimental research.

[90]  R. Sinha,et al.  Effects of adrenal sensitivity, stress- and cue-induced craving, and anxiety on subsequent alcohol relapse and treatment outcomes. , 2011, Archives of general psychiatry.

[91]  A. Heinz,et al.  Effects of alcoholism and continued abstinence on brain volumes in both genders. , 2011, Alcoholism, clinical and experimental research.

[92]  J. Kornhuber,et al.  Orexin A expression and promoter methylation in patients with alcohol dependence comparing acute and protracted withdrawal. , 2011, Alcohol.

[93]  U. Zimmermann,et al.  Modeling alcohol self-administration in the human laboratory. , 2011, Current topics in behavioral neurosciences.

[94]  S. Dickson,et al.  The alcohol-induced locomotor stimulation and accumbal dopamine release is suppressed in ghrelin knockout mice. , 2011, Alcohol.

[95]  A. Lawrence,et al.  The orexin1 receptor antagonist SB-334867 dissociates the motivational properties of alcohol and sucrose in rats , 2011, Brain Research.

[96]  J. Pratte,et al.  Simultaneous assessment of rodent behavior and neurochemistry using a miniature positron emission tomograph , 2011, Nature Methods.

[97]  D. Economidou,et al.  Activation of brain NOP receptors attenuates acute and protracted alcohol withdrawal symptoms in the rat. , 2011, Alcoholism, clinical and experimental research.

[98]  Marc N. Potenza,et al.  Individuals Family History Positive for Alcoholism Show Functional Magnetic Resonance Imaging Differences in Reward Sensitivity That Are Related to Impulsivity Factors , 2011, Biological Psychiatry.

[99]  M. Heilig,et al.  Activation of Nuclear PPARγ Receptors by the Antidiabetic Agent Pioglitazone Suppresses Alcohol Drinking and Relapse to Alcohol Seeking , 2011, Biological Psychiatry.

[100]  Ming D. Li,et al.  Pharmacogenetic approach at the serotonin transporter gene as a method of reducing the severity of alcohol drinking. , 2011, The American journal of psychiatry.

[101]  Y. Shaham,et al.  Stress-induced reinstatement of alcohol-seeking in rats is selectively suppressed by the neurokinin 1 (NK1) antagonist L822429 , 2011, Psychopharmacology.

[102]  Rajita Sinha,et al.  Association of frontal and posterior cortical gray matter volume with time to alcohol relapse: a prospective study. , 2011, The American journal of psychiatry.

[103]  G. Breese,et al.  Chronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse. , 2011, Pharmacology & therapeutics.

[104]  K. Brady,et al.  An acute psychosocial stressor increases drinking in non-treatment-seeking alcoholics , 2011, Psychopharmacology.

[105]  J. Kehne,et al.  Therapeutic utility of non-peptidic CRF1 receptor antagonists in anxiety, depression, and stress-related disorders: evidence from animal models. , 2010, Pharmacology & therapeutics.

[106]  R. Spanagel,et al.  Glycine Transporter-1 Blockade Leads to Persistently Reduced Relapse-like Alcohol Drinking in Rats , 2010, Biological Psychiatry.

[107]  Karl Mann,et al.  Initial, habitual and compulsive alcohol use is characterized by a shift of cue processing from ventral to dorsal striatum. , 2010, Addiction.

[108]  S. Kaur,et al.  Ghrelin receptor antagonism decreases alcohol consumption and activation of perioculomotor urocortin-containing neurons. , 2010, Alcoholism, clinical and experimental research.

[109]  R. Feinn,et al.  Placebo-Controlled Trial of Zonisamide for the Treatment of Alcohol Dependence , 2010, Journal of clinical psychopharmacology.

[110]  E. Vallender,et al.  A pharmacogenetic model of naltrexone-induced attenuation of alcohol consumption in rhesus monkeys. , 2010, Drug and alcohol dependence.

[111]  G. Gessa,et al.  The positive allosteric modulator of the GABA(B) receptor, rac-BHFF, suppresses alcohol self-administration. , 2010, Drug and alcohol dependence.

[112]  J. Rohrbaugh,et al.  Single-nucleotide polymorphisms in corticotropin releasing hormone receptor 1 gene (CRHR1) are associated with quantitative trait of event-related potential and alcohol dependence. , 2010, Alcoholism, clinical and experimental research.

[113]  F. Weiss,et al.  Effects of the mGlu2/3 Agonist LY379268 and the mGlu5 Antagonist MTEP on Ethanol Seeking and Reinforcement Are Differentially Altered in Rats with a History of Ethanol Dependence , 2010, Biological Psychiatry.

[114]  L. Parsons,et al.  Corticotropin Releasing Factor–Induced Amygdala Gamma-Aminobutyric Acid Release Plays a Key Role in Alcohol Dependence , 2010, Biological Psychiatry.

[115]  Stefan Gazdzinski,et al.  Cerebral white matter recovery in abstinent alcoholics--a multimodality magnetic resonance study. , 2010, Brain : a journal of neurology.

[116]  Mario Dzemidzic,et al.  Family history of alcoholism mediates the frontal response to alcoholic drink odors and alcohol in at-risk drinkers , 2010, NeuroImage.

[117]  F. Weiss,et al.  Revisiting intragastric ethanol intubation as a dependence induction method for studies of ethanol reward and motivation in rats. , 2010, Alcoholism, clinical and experimental research.

[118]  F. Weiss,et al.  Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: Focus on corticotropin-releasing factor, nociceptin/orphanin FQ, and orexin/hypocretin , 2010, Brain Research.

[119]  G. Koob.  The role of CRF and CRF-related peptides in the dark side of addiction , 2010, Brain Research.

[120]  S. Hunt,et al.  Neurokinin-1 receptors (NK1R:s), alcohol consumption, and alcohol reward in mice , 2010, Psychopharmacology.

[121]  C. Barr,et al.  Suppression of Alcohol Preference by Naltrexone in the Rhesus Macaque: A Critical Role of Genetic Variation at the μ-Opioid Receptor Gene Locus , 2010, Biological Psychiatry.

[122]  P. Randall,et al.  A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal. , 2009, Alcoholism, clinical and experimental research.

[123]  M. Picciotto,et al.  Varenicline Reduces Alcohol Self-Administration in Heavy-Drinking Smokers , 2009, Biological Psychiatry.

[124]  D. Moechars,et al.  Requirement of central ghrelin signaling for alcohol reward , 2009, Proceedings of the National Academy of Sciences.

[125]  M. Russell,et al.  Understanding and treating patients with alcoholic cirrhosis: an update. , 2009, Alcoholism, clinical and experimental research.

[126]  Rajita Sinha,et al.  Enhanced Negative Emotion and Alcohol Craving, and Altered Physiological Responses Following Stress and Cue Exposure in Alcohol Dependent Individuals , 2009, Neuropsychopharmacology.

[127]  D. Economidou,et al.  Persistent Increase of Alcohol-Seeking Evoked by Neuropeptide S: an Effect Mediated by the Hypothalamic Hypocretin System , 2009, Neuropsychopharmacology.

[128]  Peter T Fox,et al.  Differential activation of the anterior cingulate cortex and caudate nucleus during a gambling simulation in persons with a family history of alcoholism: studies from the Oklahoma Family Health Patterns Project. , 2009, Drug and alcohol dependence.

[129]  G. Koob,et al.  Effects of CRF1-receptor and opioid-receptor antagonists on dependence-induced increases in alcohol drinking by alcohol-preferring (P) rats. , 2008, Alcoholism, clinical and experimental research.

[130]  D. Hommer,et al.  IMAGING STUDY: Modulation of brain response to emotional images by alcohol cues in alcohol‐dependent patients , 2008, Addiction biology.

[131]  M. Greicius.  Resting-state functional connectivity in neuropsychiatric disorders , 2008, Current opinion in neurology.

[132]  Karl Mann,et al.  Acamprosate: recent findings and future research directions. , 2008, Alcoholism, clinical and experimental research.

[133]  G. Koob,et al.  Cellular and Behavioral Interactions of Gabapentin with Alcohol Dependence , 2008, The Journal of Neuroscience.

[134]  A. Bonci,et al.  Inhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long–Evans rats , 2008, Psychopharmacology.

[135]  T. Stiger,et al.  A 6-week randomized, placebo-controlled trial of CP-316,311 (a selective CRH1 antagonist) in the treatment of major depression. , 2008, The American journal of psychiatry.

[136]  Corinna E Löckenhoff,et al.  Five-Factor Model personality profiles of drug users , 2008, BMC psychiatry.

[137]  A. Santucci,et al.  Chronic ethanol consumption in rats produces residual increases in anxiety 4 months after withdrawal , 2008, Behavioural Brain Research.

[138]  Ariel B. Lindner,et al.  Neurokinin 1 Receptor Antagonism as a Possible Therapy for Alcoholism , 2008, Science.

[139]  R. Rimondini,et al.  PRECLINICAL STUDY: Long‐lasting tolerance to alcohol following a history of dependence , 2008, Addiction biology.

[140]  G. Koob,et al.  MPZP: A novel small molecule corticotropin-releasing factor type 1 receptor (CRF1) antagonist , 2008, Pharmacology Biochemistry and Behavior.

[141]  D. Couper,et al.  An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. , 2008, Archives of general psychiatry.

[142]  G. Koob,et al.  Effects of naltrexone, duloxetine, and a corticotropin-releasing factor type 1 receptor antagonist on binge-like alcohol drinking in rats , 2008, Behavioural pharmacology.

[143]  P. Hipskind,et al.  Upregulation of Voluntary Alcohol Intake, Behavioral Sensitivity to Stress, and Amygdala Crhr1 Expression Following a History of Dependence , 2008, Biological Psychiatry.

[144]  G. Gasbarrini,et al.  Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study , 2007, The Lancet.

[145]  L. Parsons,et al.  CRF–CRF1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats , 2007, Proceedings of the National Academy of Sciences.

[146]  D. Ciraulo,et al.  Topiramate for treating alcohol dependence: a randomized controlled trial. , 2007, JAMA.

[147]  D. Gutman,et al.  The CRF1 receptor antagonist, R121919, attenuates the severity of precipitated morphine withdrawal. , 2007, European journal of pharmacology.

[148]  G. Koob,et al.  Stress, dysregulation of drug reward pathways, and the transition to drug dependence. , 2007, The American journal of psychiatry.

[149]  S. Bartlett,et al.  Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking , 2007, Proceedings of the National Academy of Sciences.

[150]  C. Kornetsky,et al.  Zonisamide decreases ethanol intake in rats and mice , 2007, Pharmacology Biochemistry and Behavior.

[151]  Mark Slifstein,et al.  Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine. , 2007, The American journal of psychiatry.

[152]  G. Koob,et al.  Dependence-induced increases in ethanol self-administration in mice are blocked by the CRF1 receptor antagonist antalarmin and by CRF1 receptor knockout , 2007, Pharmacology Biochemistry and Behavior.

[153]  P. Hipskind,et al.  3-(4-Chloro-2-Morpholin-4-yl-Thiazol-5-yl)-8-(1-Ethylpropyl)-2,6-Dimethyl-Imidazo[1,2-b]Pyridazine: A Novel Brain-Penetrant, Orally Available Corticotropin-Releasing Factor Receptor 1 Antagonist with Efficacy in Animal Models of Alcoholism , 2007, The Journal of Neuroscience.

[154]  G. Venkatasubramanian,et al.  IMAGING STUDY: Gray matter volume abnormalities and externalizing symptoms in subjects at high risk for alcohol dependence , 2007, Addiction biology.

[155]  S. Nguyen,et al.  Topiramate reduces ethanol consumption by C57BL/6 mice , 2007, Synapse.

[156]  A. Hansson,et al.  PRECLINICAL STUDY: Region‐specific down‐regulation of Crhr1 gene expression in alcohol‐preferring msP rats following ad lib access to alcohol , 2007, Addiction biology.

[157]  G. Gessa,et al.  Cue-induced reinstatement of ethanol seeking in Sardinian alcohol-preferring rats. , 2007, Alcohol.

[158]  G. Koob,et al.  Corticotropin-Releasing Factor 1 Antagonists Selectively Reduce Ethanol Self-Administration in Ethanol-Dependent Rats , 2007, Biological Psychiatry.

[159]  D. Economidou,et al.  Buprenorphine Reduces Alcohol Drinking Through Activation of the Nociceptin/Orphanin FQ-NOP Receptor System , 2007, Biological Psychiatry.

[160]  M. Schocke,et al.  A widespread distinct pattern of cerebral atrophy in patients with alcohol addiction revealed by voxel-based morphometry , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[161]  G. Koob,et al.  Corticotropin-Releasing Factor within the Central Nucleus of the Amygdala Mediates Enhanced Ethanol Self-Administration in Withdrawn, Ethanol-Dependent Rats , 2006, The Journal of Neuroscience.

[162]  G. Koob,et al.  Dissociation between opioid and CRF1 antagonist sensitive drinking in Sardinian alcohol-preferring rats , 2006, Psychopharmacology.

[163]  A. C. Hansson,et al.  Variation at the rat Crhr1 locus and sensitivity to relapse into alcohol seeking induced by environmental stress , 2006, Proceedings of the National Academy of Sciences.

[164]  S. Rombouts,et al.  Consistent resting-state networks across healthy subjects , 2006, Proceedings of the National Academy of Sciences.

[165]  M. Heilig,et al.  Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms. , 2006, Pharmacology & therapeutics.

[166]  Peter F. Neher,et al.  Brain atrophy in long-term abstinent alcoholics who demonstrate impairment on a simulated gambling task , 2006, NeuroImage.

[167]  Maurizio Massi,et al.  REVIEW: Genetically selected Marchigian Sardinian alcohol‐preferring (msP) rats: an animal model to study the neurobiology of alcoholism , 2006, Addiction biology.

[168]  A. Lawrence,et al.  The orexin system regulates alcohol‐seeking in rats , 2006, British journal of pharmacology.

[169]  D. Rujescu,et al.  Genetic association of the human corticotropin releasing hormone receptor 1 (CRHR1) with binge drinking and alcohol intake patterns in two independent samples , 2006, Molecular Psychiatry.

[170]  Jesse J. Suh,et al.  The Status of Disulfiram: A Half of a Century Later , 2006, Journal of clinical psychopharmacology.

[171]  David Couper,et al.  Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. , 2006, JAMA.

[172]  A. Lawrence,et al.  The GABAB receptor allosteric modulator CGP7930, like baclofen, reduces operant self-administration of ethanol in alcohol-preferring rats , 2006, Neuropharmacology.

[173]  Darci M. Nielsen.  Corticotropin-releasing factor type-1 receptor antagonists: the next class of antidepressants? , 2006, Life sciences.

[174]  G. Gessa,et al.  Reducing effect of the positive allosteric modulators of the GABA(B) receptor, CGP7930 and GS39783, on alcohol intake in alcohol-preferring rats. , 2005, European journal of pharmacology.

[175]  M. Massi,et al.  Reduction of ethanol intake by chronic treatment with Hypericum perforatum, alone or combined with naltrexone in rats , 2005, Journal of psychopharmacology.

[176]  A. Lawrence,et al.  The acute anti‐craving effect of acamprosate in alcohol‐preferring rats is associated with modulation of the mesolimbic dopamine system , 2005, Addiction biology.

[177]  David Goldman,et al.  The genetics of addictions: uncovering the genes , 2005, Nature Reviews Genetics.

[178]  Christian F. Beckmann,et al.  Investigations into resting-state connectivity using independent component analysis , 2005, Philosophical Transactions of the Royal Society B: Biological Sciences.

[179]  Rajita Sinha,et al.  Stress enhancement of craving during sobriety: a risk for relapse. , 2005, Alcoholism, clinical and experimental research.

[180]  G. Koob,et al.  The therapeutic potential of CRF1 antagonists for anxiety , 2004, Expert opinion on investigational drugs.

[181]  C. Bouza,et al.  Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review. , 2004, Addiction.

[182]  Yiyun Huang,et al.  Cocaine Dependence and D2 Receptor Availability in the Functional Subdivisions of the Striatum: Relationship with Cocaine-Seeking Behavior , 2004, Neuropsychopharmacology.

[183]  Edward V Nunes,et al.  Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis. , 2004, JAMA.

[184]  Mario Dzemidzic,et al.  Alcohol-related olfactory cues activate the nucleus accumbens and ventral tegmental area in high-risk drinkers: preliminary findings. , 2004, Alcoholism, clinical and experimental research.

[185]  D. Economidou,et al.  Attenuation of ethanol self-administration and of conditioned reinstatement of alcohol-seeking behaviour by the antiopioid peptide nociceptin/orphanin FQ in alcohol-preferring rats , 2004, Psychopharmacology.

[186]  D. Overstreet,et al.  SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats. , 2004, Alcohol.

[187]  W. Vale,et al.  CRF and CRF receptors: role in stress responsivity and other behaviors. , 2004, Annual review of pharmacology and toxicology.

[188]  Ting-kai Li,et al.  A comparative study on alcohol-preferring rat lines: effects of deprivation and stress phases on voluntary alcohol intake. , 2003, Alcoholism, clinical and experimental research.

[189]  R. Feinn,et al.  Effects of ondansetron in early- versus late-onset alcoholics: a prospective, open-label study. , 2003, Alcoholism, clinical and experimental research.

[190]  D. Oslin,et al.  A Functional Polymorphism of the μ-Opioid Receptor Gene is Associated with Naltrexone Response in Alcohol-Dependent Patients , 2003, Neuropsychopharmacology.

[191]  Jennie Z Ma,et al.  Oral topiramate for treatment of alcohol dependence: a randomised controlled trial , 2003, The Lancet.

[192]  S. File,et al.  Corticotropin releasing factor antagonist, α-helical CRF9–41, reverses nicotine-induced conditioned, but not unconditioned, anxiety , 2003, Psychopharmacology.

[193]  F. Weiss,et al.  Reinstatement of ethanol-seeking behavior by drug cues following single versus multiple ethanol intoxication in the rat: effects of naltrexone , 2003, Psychopharmacology.

[194]  L. Terenius,et al.  Acquisition, Expression, and Reinstatement of Ethanol-Induced Conditioned Place Preference in Mice: Effects of Opioid Receptor-Like 1 Receptor Agonists and Naloxone , 2003, Journal of Pharmacology and Experimental Therapeutics.

[195]  F. Weiss,et al.  Additive Effect of Stress and Drug Cues on Reinstatement of Ethanol Seeking: Exacerbation by History of Dependence and Role of Concurrent Activation of Corticotropin-Releasing Factor and Opioid Mechanisms , 2002, The Journal of Neuroscience.

[196]  G. Gessa,et al.  The GABA(B) receptor agonists baclofen and CGP 44532 prevent acquisition of alcohol drinking behaviour in alcohol-preferring rats. , 2002, Alcohol and alcoholism.

[197]  C. Nemeroff,et al.  Parental depression: animal models of an adverse life event. , 2002, The American journal of psychiatry.

[198]  C. Hodge,et al.  Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake , 2002, Pharmacology Biochemistry and Behavior.

[199]  G Fein,et al.  Cortical gray matter loss in treatment-naïve alcohol dependent individuals. , 2002, Alcoholism, clinical and experimental research.

[200]  F. Weiss,et al.  Reversal of ethanol-seeking behavior by D1 and D2 antagonists in an animal model of relapse: differences in antagonist potency in previously ethanol-dependent versus nondependent rats. , 2002, The Journal of pharmacology and experimental therapeutics.

[201]  G. Gessa,et al.  Rapid suppression of alcohol withdrawal syndrome by baclofen. , 2002, The American journal of medicine.

[202]  C. Hodge,et al.  Effects of acute acamprosate and homotaurine on ethanol intake and ethanol-stimulated mesolimbic dopamine release. , 2002, European journal of pharmacology.

[203]  J. Roache,et al.  Ondansetron reduces the craving of biologically predisposed alcoholics , 2002, Psychopharmacology.

[204]  P. Hyytiä,et al.  Naltrexone suppresses ethanol intake in 6-hydroxydopamine-treated rats. , 2001, Alcoholism, clinical and experimental research.

[205]  R. Sinha.  How does stress increase risk of drug abuse and relapse? , 2001, Psychopharmacology.

[206]  F. Weiss,et al.  Long-lasting resistance to extinction of response reinstatement induced by ethanol-related stimuli: role of genetic ethanol preference. , 2001, Alcoholism, clinical and experimental research.

[207]  F. Weiss,et al.  Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats , 2001, Psychopharmacology.

[208]  L. Parsons,et al.  Compulsive Drug‐Seeking Behavior and Relapse , 2001 .

[209]  F. Crews,et al.  Effects of nicotine on ethanol dependence and brain damage. , 2001, Alcohol.

[210]  J. Volpicelli,et al.  Effect of acamprosate and naltrexone, alone or in combination, on ethanol consumption. , 2001, Alcohol.

[211]  P. Sawchenko,et al.  Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse , 2000, The Journal of comparative neurology.

[212]  G. Kaplan,et al.  Naltrexone's effects on reactivity to alcohol cues among alcoholic men. , 2000, Journal of abnormal psychology.

[213]  A T McLellan,et al.  Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. , 2000, JAMA.

[214]  G. Gessa,et al.  Gamma‐hydroxybutyric acid in alcohol preference, dependence and withdrawal , 2000, Addiction biology.

[215]  J. Hensler,et al.  Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: A randomized controlled trial. , 2000, JAMA.

[216]  F. Weiss,et al.  Nociceptin prevents stress‐induced ethanol‐but not cocaine‐seeking behavior in rats , 2000, Neuroreport.

[217]  J S Fowler,et al.  Regional brain metabolism during alcohol intoxication. , 2000, Alcoholism, clinical and experimental research.

[218]  E. Capristo,et al.  Gamma-hydroxybutyric acid efficacy, potential abuse, and dependence in the treatment of alcohol addiction. , 2000, Alcohol.

[219]  D. Overstreet,et al.  P rats develop physical dependence on alcohol via voluntary drinking: changes in seizure thresholds, anxiety, and patterns of alcohol drinking. , 2000, Alcoholism, clinical and experimental research.

[220]  Richard A. Brown,et al.  Naltrexone's effect on cue-elicited craving among alcoholics in treatment. , 1999, Alcoholism, clinical and experimental research.

[221]  R. Spanagel,et al.  Effects of opiate antagonist treatment on the alcohol deprivation effect in long-term ethanol-experienced rats , 1999, Psychopharmacology.

[222]  B. Mason,et al.  A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence. , 1999, Archives of general psychiatry.

[223]  G. Koob,et al.  Corticotropin-releasing factor antagonist attenuates the “anxiogenic-like” effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats , 1999, Psychopharmacology.

[224]  T. Insel,et al.  Autoradiographic and in situ hybridization localization of corticotropin‐releasing factor 1 and 2 receptors in nonhuman primate brain , 1999, The Journal of comparative neurology.

[225]  F. Weiss,et al.  Reinstatement of Alcohol-Seeking Behavior by Drug-Associated Discriminative Stimuli after Prolonged Extinction in the Rat , 1999, Neuropsychopharmacology.

[226]  K. Lohr,et al.  Pharmacological treatment of alcohol dependence: a review of the evidence. , 1999, JAMA.

[227]  R. Sinha,et al.  Craving for alcohol: findings from the clinic and the laboratory. , 1999, Alcohol and alcoholism.

[228]  Ting-kai Li,et al.  The alcohol deprivation effect in the alcohol-preferring P rat under free-drinking and operant access conditions. , 1998, Alcoholism, clinical and experimental research.

[229]  J. Volpicelli,et al.  A comparison of the effects of the opioid antagonists naltrexone, naltrindole, and beta-funaltrexamine on ethanol consumption in the rat. , 1998, Alcohol.

[230]  P. Portoghese,et al.  Effect of Mu Opioid Receptor Blockade on Alcohol Intake in Rats Bred for High Alcohol Drinking , 1998, Pharmacology Biochemistry and Behavior.

[231]  S. Carr,et al.  Orexins and Orexin Receptors: A Family of Hypothalamic Neuropeptides and G Protein-Coupled Receptors that Regulate Feeding Behavior , 1998, Cell.

[232]  R. Spanagel,et al.  Long-term ethanol self-administration with repeated ethanol deprivation episodes changes ethanol drinking pattern and increases anxiety-related behaviour during ethanol deprivation in rats , 1998, Behavioural pharmacology.

[233]  C. Heyser,et al.  Chronic Acamprosate Eliminates the Alcohol Deprivation Effect While Having Limited Effects on Baseline Responding for Ethanol in Rats , 1998, Neuropsychopharmacology.

[234]  F E Bloom,et al.  The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[235]  Anna Rose Childress,et al.  Conditioning factors in drug abuse: can they explain compulsion? , 1998, Journal of psychopharmacology.

[236]  D. Gallager,et al.  Autoradiographic Localization of CRF1 and CRF2 Binding Sites in Adult Rat Brain , 1997, Neuropsychopharmacology.

[237]  G F Koob,et al.  Drug abuse: hedonic homeostatic dysregulation. , 1997, Science.

[238]  H. Little,et al.  The novel anticonvulsant, gabapentin, protects against both convulsant and anxiogenic aspects of the ethanol withdrawal syndrome , 1997, Neuropharmacology.

[239]  J S Fowler,et al.  Regional brain metabolic response to lorazepam in alcoholics during early and late alcohol detoxification. , 1997, Alcoholism, clinical and experimental research.

[240]  C. Heyser,et al.  Increased ethanol self-administration after a period of imposed ethanol deprivation in rats trained in a limited access paradigm. , 1997, Alcoholism, clinical and experimental research.

[241]  R. Spanagel,et al.  Time course of acamprosate action on operant ethanol self-administration after ethanol deprivation. , 1997, Alcoholism, clinical and experimental research.

[242]  M. Begelman,et al.  Intermittent Radio Galaxies and Source Statistics , 1997, astro-ph/9707221.

[243]  G. Koob,et al.  Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. , 1997, Science.

[244]  K. Kendler,et al.  Temperance board registration for alcohol abuse in a national sample of Swedish male twins, born 1902 to 1949. , 1997, Archives of general psychiatry.

[245]  C. Robert Cloninger,et al.  Replication of the Stockholm Adoption Study of alcoholism. Confirmatory cross-fostering analysis. , 1996, Archives of general psychiatry.

[246]  K. Mann,et al.  Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence. , 1996, Archives of general psychiatry.

[247]  M. Bernardi,et al.  An open multicentric study evaluating 4-hydroxybutyric acid sodium salt in the medium-term treatment of 179 alcohol dependent subjects. GHB Study Group. , 1996, Alcohol and alcoholism.

[248]  K O Lim,et al.  Longitudinal changes in magnetic resonance imaging brain volumes in abstinent and relapsed alcoholics. , 1995, Alcoholism, clinical and experimental research.

[249]  G. Koob,et al.  Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[250]  J. Guelfi,et al.  Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol. , 1995, Alcohol and alcoholism.

[251]  B. Mason,et al.  A Double‐Blind, Placebo‐Controlled Pilot Study to Evaluate the Efficacy and Safety of Oral Nalmefene HCI for Alcohol Dependence , 1994 .

[252]  J S Fowler,et al.  Recovery of brain glucose metabolism in detoxified alcoholics. , 1994, The American journal of psychiatry.

[253]  A. Alterman,et al.  Naltrexone in the treatment of alcohol dependence. , 1992, Archives of general psychiatry.

[254]  B. Rounsaville,et al.  Naltrexone and coping skills therapy for alcohol dependence. A controlled study. , 1992, Archives of general psychiatry.

[255]  G. Gessa,et al.  gamma-Hydroxybutyric acid in the treatment of alcohol dependence: a double-blind study. , 1992, Alcoholism, clinical and experimental research.

[256]  W. Miller,et al.  Long-term follow-up of behavioral self-control training. , 1992, Journal of studies on alcohol.

[257]  R A Koeppe,et al.  Cerebellar and frontal hypometabolism in alcoholic cerebellar degeneration studied with positron emission tomography , 1990, Annals of neurology.

[258]  Ting-kai Li,et al.  Long and short alcohol deprivation: effects on AA and P alcohol-preferring rats. , 1989, Alcohol.

[259]  J. Durlach,et al.  Dose-dependent suppression of the high alcohol intake of chronically intoxicated rats by Ca-acetyl homotaurinate. , 1987, Alcohol.

[260]  Ting-kai Li,et al.  Induction of dependence on ethanol by free-choice drinking in alcohol-preferring rats , 1982, Pharmacology Biochemistry and Behavior.

[261]  C. Robert Cloninger,et al.  Inheritance of alcohol abuse. Cross-fostering analysis of adopted men. , 1981, Archives of general psychiatry.

[262]  E. Majchrowicz.  Induction of physical dependence upon ethanol and the associated behavioral changes in rats , 1975, Psychopharmacologia.

[263]  W. Bunney,et al.  Animal model of depression. I. Review of evidence: implications for research. , 1969, Archives of general psychiatry.

[264]  Sinclair Jd,et al.  Development of an alcohol-deprivation effect in rats. , 1968 .

[265]  J. Mendelson,et al.  [EXPERIMENTALLY INDUCED CHRONIC ALCOHOLIC INTOXICATION AND ITS SUSPENSION. I. PSYCHOTOXICOLOGIC RESULTS]. , 1964, Hippokrates.

[266]  F. Weiss,et al.  NOP-Related Mechanisms in Substance Use Disorders. , 2019, Handbook of experimental pharmacology.

[267]  R. Ciccocioppo,et al.  Emerging targets for addiction neuropharmacology: From mechanisms to therapeutics. , 2016, Progress in brain research.

[268]  D. Hommer,et al.  Reduced anterior insula, enlarged amygdala in alcoholism and associated depleted von Economo neurons. , 2015, Brain : a journal of neurology.

[269]  Laura B. Ferguson,et al.  Peroxisome proliferator-activated receptors α and γ are linked with alcohol consumption in mice and withdrawal and dependence in humans. , 2015, Alcoholism, clinical and experimental research.

[270]  Robert L Barry,et al.  Phosphodiesterase 10 A Regulates Alcohol and Saccharin Self-Administration in Rats , 2014 .

[271]  S. Quello,et al.  Gabapentin treatment for alcohol dependence: a randomized clinical trial. , 2014, JAMA internal medicine.

[272]  G. Koob.  Neurocircuitry of alcohol addiction: synthesis from animal models. , 2014, Handbook of clinical neurology.

[273]  R. Sinha.  Modeling relapse situations in the human laboratory. , 2013, Current topics in behavioral neurosciences.

[274]  H. Becker.  Animal models of excessive alcohol consumption in rodents. , 2013, Current topics in behavioral neurosciences.

[275]  M. Heilig,et al.  Translational approaches to medication development. , 2013, Current topics in behavioral neurosciences.

[276]  D. Hommer,et al.  Subjective and Neural Responses to Intravenous Alcohol in Young Adults with Light and Heavy Drinking Patterns , 2012, Neuropsychopharmacology.

[277]  Paul Vaska,et al.  Integrating PET with behavioral neuroscience using RatCAP tomography , 2011, Reviews in the neurosciences.

[278]  N. Volkow,et al.  Neurocircuitry of Addiction , 2010, Neuropsychopharmacology.

[279]  R. Ciccocioppo,et al.  Neuropeptide S receptor gene expression in alcohol withdrawal and protracted abstinence in postdependent rats. , 2010, Alcoholism, clinical and experimental research.

[280]  C. Li,et al.  Imaging stress- and cue-induced drug and alcohol craving: association with relapse and clinical implications. , 2007, Drug and alcohol review.

[281]  S. Bartlett,et al.  Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking. , 2007, Proceedings of the National Academy of Sciences of the United States of America.

[282]  A. Lawrence,et al.  The GABA(B) receptor allosteric modulator CGP7930, like baclofen, reduces operant self-administration of ethanol in alcohol-preferring rats. , 2006, Neuropharmacology.

[283]  J. M. Ree,et al.  Effect of naltrexone on alcohol consumption during chronic alcohol drinking and after a period of imposed abstinence in free-choice drinking rhesus monkeys , 2005, Psychopharmacology.

[284]  P. Willner,et al.  The validity of animal models of depression , 2004, Psychopharmacology.

[285]  C. Heyser,et al.  Animal models of motivation for drinking in rodents with a focus on opioid receptor neuropharmacology. , 2003, Recent developments in alcoholism : an official publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism.

[286]  L. Parsons,et al.  Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors. , 2001, Annals of the New York Academy of Sciences.

[287]  Ting-kai Li,et al.  Alcohol deprivation effect is prolonged in the alcohol preferring (P) rat after repeated deprivations. , 2000, Alcoholism, clinical and experimental research.

[288]  G. Gessa,et al.  Ability of baclofen in reducing alcohol craving and intake: II--Preliminary clinical evidence. , 2000, Alcoholism, clinical and experimental research.

[289]  R. Spanagel,et al.  Pharmacological validation of a new animal model of alcoholism , 2000, Journal of Neural Transmission.

[290]  D J Rohsenow,et al.  Toward bridging the gap between biological, psychobiological and psychosocial models of alcohol craving. , 2000, Addiction.

[291]  G J Connors,et al.  Treating Problem Drinking , 1999, Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism.

[292]  K. Kendler,et al.  Genetic and environmental contributions to alcohol abuse and dependence in a population-based sample of male twins. , 1999, The American journal of psychiatry.

[293]  C. Polidori,et al.  Effect of nociceptin on alcohol intake in alcohol-preferring rats , 1999, Psychopharmacology.

[294]  P. Fletcher,et al.  Reinstatement of alcohol-seeking by priming injections of alcohol and exposure to stress in rats , 1998, Psychopharmacology.

[295]  G. Koob.  CIRCUITS, DRUGS, AND DRUG ADDICTION , 1997 .

[296]  M A Schuckit,et al.  Stress, vulnerability and adult alcohol relapse. , 1995, Journal of studies on alcohol.

[297]  N. O'mara,et al.  Naltrexone in the treatment of alcohol dependence. , 1994, The Annals of pharmacotherapy.

[298]  Harold Rosenberg.  Prediction of controlled drinking by alcoholics and problem drinkers. , 1993, Psychological bulletin.

[299]  B. Duron,et al.  [Effect of acute administration of acamprosate on the risk of encephalopathy and on arterial pressure in patients with alcoholic cirrhosis]. , 1992, Gastroenterologie clinique et biologique.

[300]  J S Fowler,et al.  Decreased brain metabolism in neurologically intact healthy alcoholics. , 1992, The American journal of psychiatry.

[301]  M. Zuckerman,et al.  Sensation seeking and the endogenous deficit theory of drug abuse. , 1986, NIDA research monograph.

[302]  R. Senter,et al.  Development of an alcohol-deprivation effect in rats. , 1968, Quarterly journal of studies on alcohol.